Results for tag: "Geographic Atrophy Drug"

Geographic Atrophy (GA) is a type of advanced age-related macular degeneration (AMD) that causes progressive vision loss. It is caused by the death of photoreceptor cells in the macula, the central part of the retina responsible for sharp, central vision. GA is the most advanced form of AMD and is the leading cause of blindness in the elderly. Optical Disorders Drugs are used to treat GA and other forms of AMD. These drugs are designed to slow the progression of the disease and improve vision. Common treatments include anti-VEGF drugs, which block the growth of new blood vessels in the eye, and photodynamic therapy, which uses light to activate a drug that destroys abnormal blood vessels. The Geographic Atrophy Drug market is a rapidly growing segment of the Optical Disorders Drugs market. It is driven by the increasing prevalence of AMD and the need for effective treatments. Companies in this market include Regeneron Pharmaceuticals, Novartis, Allergan, and Roche. Show Less Read more